Page URL:

Genetic test could identify breast cancer risk

8 May 2012
Appeared in BioNews 655

A link between modifications to a white blood cell gene and an increased risk of breast cancer could be the basis for a simple blood test to identify women most at risk of developing the disease.

Researchers found that women whose ATM gene had higher levels of a chemical modification called methylation were twice as likely to go on to develop breast cancer, compared to those with lower levels.

'We know that genetic variation contributes to a person's risk of disease', explained study leader Dr James Flanagan. 'With this new study we can now also say that epigenetic variation, or differences in how genes are modified, also has a role'.

Of the 1,380 women analysed in the study, published in Cancer Research, 640 developed breast cancer. These women were of various ages, but the results were most clear in those under 60.

In one case, high levels of ATM methylation pre-dated breast cancer diagnosis by eleven years, suggesting that it might be possible to identify the risk many years in advance. However, the average amount of time the blood test pre-dated cancer diagnosis was only three years.

This modification may therefore act as an early warning sign for the disease and the team hopes it will allow them to develop a simple blood test to monitor high-risk patients more closely.

While it is unclear how a blood cell gene might affect breast cancer, ATM is known to be mutated in a number of other cancers including leukaemia, and is thought to have a role in DNA damage repair.

Baroness Delyth Morgan of Breast Cancer Campaign said: 'By piecing together how this happens, we can look at ways of preventing the disease and detecting it earlier to give people the best possible chance of survival'.

However, more research will be needed to determine whether a blood test can predict breast cancer before it develops, meaning that it would be a still be a number of years before such a test becomes available.

Dr Flanagan is keen to look at epigenetic modifications elsewhere, saying that the 'next step […] is a genome-wide approach to try and find all the associated genes'.

'We hope that this research is just the beginning of our understanding about the epigenetic component of breast cancer risk', he added. 'The challenge will be how to incorporate all of this new information into the computer models that are currently used for individual risk prediction'.

Blood test could detect breast cancer risk
Guardian |  30 April 2012
Blood Test To Detect Most 'At Risk' From Breast Cancer
Huffington Post |  2 May 2012
'Breast cancer blood test' needs more work
NHS Choices: Behind the Headlines |  2 May 2012
Gene test that could predict breast cancer years before it strikes
Daily Mail |  1 May 2012
Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
Cancer Research |  1 May 2012
Way to spot breast cancer years in advance
BBC |  1 May 2012
15 July 2013 - by Julianna Photopoulos 
Scientists have developed a 'barcode' blood test that reads genetic changes to pick out the most aggressive prostate cancers...
21 January 2013 - by Dr Lux Fatimathas 
Women at high risk of developing breast cancer should be offered preventative drugs, suggests the National Institute for Health and Clinical Excellence in updated guidelines...
1 October 2012 - by Dr Zara Mahmoud 
Scientists have found molecular similarities between a subtype of breast cancer and a hard-to-treat form of ovarian cancer...
10 September 2012 - by Daryl Ramai 
Women carrying mutations in their BRCA genes may be more susceptible to breast cancer if exposed to diagnostic chest X-rays before the age of 30, say scientists...
9 July 2012 - by Ruth Saunders 
Two novel gene variants linked to breast size may also also influence the risk of breast cancer, according to a study carried out by US genetics company 23andMe....
23 April 2012 - by Dr Linda Wijlaars 
Breast cancer can be reclassified into ten separate 'diseases' based on its genetic characteristics, according to scientists. Analysis of the DNA and RNA from almost 2,000 tumours identified ten genetically different subtypes of breast cancer with different survival outcomes. The information could be used to better predict the outcomes of the disease, as well as offer tailored treatment to patients...
2 April 2012 - by Dr Sarah Spain 
The US Supreme Court has ordered that the two gene patents held by Myriad Genetics be sent back to the US Court of Appeals for the Federal Circuit, to be re-examined...
26 March 2012 - by Sarah Pritchard 
A genetic test could be used to spare breast cancer patients from having to undergo postoperative chemotherapy...
31 January 2012 - by Dr Maria Botcharova 
Two breast cancer drugs, Avastin and Sutent, may inadvertently aid cancer growth, a study in mice suggests. The drugs, designed to reduce the blood supply to tumours, were found to encourage cancer stem cell growth, potentially fuelling the spread of the cancer...
19 December 2011 - by Dr Rebecca Robey 
Women who inherit breast cancer risk genes from their father may be diagnosed with, or even develop, the disease several years earlier than those who inherit the same genes from their mother. This may have implications for screening and treatment strategies for those at risk of hereditary breast cancer...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.